Postpartum depression (PPD) is a relatively common problem, affecting between 10% and 15% of women after delivery. Although it is difficult to reliably predict which women in the general population will experience postpartum depression, it [...]
Postpartum depression first gained medical attention in the 1970’s. While postpartum depression is similar to depression occurring at other times in a woman’s life, we have learned over time that many women with what we [...]
The COVID-19 pandemic has impacted the way antenatal care is being delivered in the United States, such as having fewer visits and replacing some in-clinic visits with virtual visits over telemedicine platforms. There has been [...]
In a given year, about 10% of mothers in the United States experience a major depressive episode (MDE). Roughly translated, this means about 1 in 10 children is exposed to maternal depression each year (Ertel [...]
In 2019, brexanolone was introduced by Sage Therapeutics as Zulresso, a novel treatment for postpartum depression. The oral version of this novel antidepressant – SAGE 217 or zuranolone – is now finishing up its Phase [...]
While for some adults, attention-deficit/hyperactivity disorder (ADHD) is relatively mild and, with effective treatment, does not have a significant impact on overall functioning or quality of life. However, it is noteworthy that the majority of [...]
About 15% of women will experience postpartum depression after the birth of a child. While most of those women will have unipolar depression, a certain number of women will have bipolar depression. At this juncture, [...]
Suicide is a leading cause of maternal mortality in the United States. According to a 2017 study from California, drug-related deaths (3.68 per 100,000 person-years) and suicides (1.42 per 100,000 person-years) accounted for nearly [...]
Post-traumatic stress disorder (PTSD) is common among women of child-bearing age. While we are increasingly attentive to screening for depressive symptoms during pregnancy and after delivery, less often do we inquire about PTSD symptoms. [...]
The US Preventive Services Task Force (USPSTF) issued recommendations that all pregnant and postpartum women should be evaluated in order to determine risk for depressive illness and recommends that women at increased risk for [...]
